NME Goal Dates Sparse In Late 2007: Third Year Of Low NME Count Likely
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Only three NDAs for new molecular entities have user fee goal dates in the remainder of 2007, which implies a marked slow-down in the pace of NME actions after FDA’s busy October.